Today’s Consort Medical founded as “Bespak” supplying valves for cosmetics and consumer markets (King’s Lynn).
Gained contract with GSK for Ventolin thus entering the pharmaceutical market.
Moved to King’s Lynn where Bespak remains today.
Awarded Diskus® manufacturing contract by GSK.
Launched HFA valve to replace CFC variant.
Cramlington site business sold as a business to Aesica Pharmaceuticals Ltd in September 2004.
Group’s name changed to Consort Medical plc. Aesica Pharmaceuticals aqcuired the Queenborough site.
Acquired The Medical House, a specialist in auto injectors.
500 millionth Diskus® device manufactured for GSK.
Entered point of care diagnostics market in partnership with Atlas Genetics.
Monheim, Zwickau and Pianezza became part of Aesica Pharmaceuticals Ltd.
Awarded contract with Nicoventures for licensed nicotine delivery product.
Unveiled Syrina®, Vapoursoft® and Lila® range of innovative injection devices.
Secured first MHRA licence for commercial drug handling.
Acquisition of Aesica Pharmaceuticals by Consort Medical plc.
Regulatory approval and launch of Bespak’s first auto-injector (for Dr. Reddy’s).
Agreement with SteadyMed for development of wearable infusion delivery device.
Unveiled Lapas® range of innovative bolus injection devices.
2 billionth HFA MDI Valve manufactured.
Bespak brings into operation, at it’s King’s Lynn site, the UK’s largest cleanroom at the time of construction.
Signed significant development and manufacturing collaboration agreement with Oxular “formerly Precision Ocular”.
Regulatory approval and UK launch for UCB’s Cimzia Auto injector with core Bespak technology.
Signed AstraZeneca scale-up and commercial supply agreement for Bespak proprietary pMDI valves and actuators.
750 millionth Diskus device manufactured for GSK.
Bespak Injection Moulding Academy opened.
FDA approval received for Mylan’s generic version of Advair.